GridAI Technologies Corp DEFA14A, filed Dec 17, 2021
GridAI Technologies Corp. (GRDX)
DEFA14A
2021-12-17
View Original
Added on
October 17, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the SEC Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to 14a-12
|
FIRST WAVE BIOPHARMA, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required.
|
| ☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
1.
|
Title of each class of securities to which transaction applies:
|
|
2.
|
Aggregate number of securities to which transaction applies:
|
|
3.
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4.
|
Proposed maximum aggregate value of transaction:
|
|
5.
|
Total fee paid:
|
| ☐ |
Fee paid previously with preliminary materials.
|
| ☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date of its filing.
|
|
1.
|
Amount Previously Paid:
|
|
2.
|
Form, Schedule or Registration Statement No.:
|
|
3.
|
Filing Party:
|
|
4.
|
Date Filed:
|
On December 17, 2021, Alliance Advisors LLC, who has been retained by First Wave BioPharma, Inc. as proxy solicitor for their annual meeting of stockholders, sent the following letter to certain stockholders:
 |
 |
December 17, 2021
URGENT
Re: Your investment in: First Wave Biopharma, Inc.
Dear Stockholder,
Alliance Advisors has been engaged by First Wave Biopharma, Inc. to contact you regarding an important matter
pertaining to your investment in First Wave Biopharma, Inc.
Our previous attempts to contact you have been unsuccessful. Please contact us immediately at 1-833-782-7196 between the hours of 9:00am and 10:00pm Eastern time,
Monday through Friday and Saturday and Sunday from 10:00am to 6:00pm.
This matter is very important and will take only a moment of your time.
Thank you in advance for your assistance with this matter.
Sincerely,
Gina Balderas
Operations Manager